A year of policy and productivity

The ongoing AI revolution is significantly impacting infrastructure investments, benefiting companies involved in data center construction, energy modernization, and component supply. These investments are expected to have long-term transformative effects on the economy by revitalizing US industrial activity and enhancing capacity and output. The true potential of AI lies in its ability to transform business operations, particularly in sectors with high labor costs, such as health care, software, industrials, and retail, by reducing costs and driving innovation.

As inflation pressures ease and consumer-driven growth slows, companies are likely to shift their focus to productivity and efficiency investments. This shift could unlock substantial economic value through automation and AI, fostering innovation and revitalizing US productivity, which has stagnated since the early 2000s. Trade barriers may further incentivize domestic innovation, allowing companies to offset cost pressures with productivity gains, ultimately leading to sustained profitability improvements.

The Health Care sector, particularly Biotech, is poised for a potential rebound after years of underperformance due to macroeconomic pressures and high interest rates. As economic growth moderates and interest rates decline by 2025, financing burdens for biotech companies are expected to ease. With regulatory fears largely priced into stocks, the sector could experience renewed investor interest driven by drug development innovations and the adoption of AI in health care, enhancing efficiency and breakthroughs.